13 October 2017 in Immunological Reviews
18 April 2015 in Journal of Bone and Mineral Research
Increased diacylglycerol (DAG) levels are observed in numerous pathologies, including conditions associated with bone loss. However, the effects of DAG accumulation on the skeleton have never been directly examined. Because DAG is strictly controlled by tissue‐specific diacylglycerol kinases (DGKs), we sought to examine the biological consequences of DAG accumulation on bone homeostasis by genetic deletion of DGKζ, a highly expressed DGK isoform in osteoclasts (OCs). Strikingly, DGKζ‐/‐ mice are osteoporotic because of a marked increase in OC numbers. In vitro, DGKζ‐/‐ bone marrow macrophages (BMMs) form more numerous, larger, and highly resorptive OCs. Surprisingly, although increased DAG levels do not alter receptor activator of NF‐κB (RANK)/RANK ligand (RANKL) osteoclastogenic pathway, DGKζ deficiency increases responsiveness to the proliferative and pro‐survival cytokine macrophage colony‐stimulating factor (M‐CSF). We find that M‐CSF is responsible for increased DGKζ‐/‐ OC differentiation by promoting higher expression of the transcription factor c‐Fos, and c‐Fos knockdown in DGKζ‐/‐ cultures dose‐dependently reduces OC differentiation. Using a c‐Fos luciferase reporter assay lacking the TRE responsive element, we also demonstrate that M‐CSF induces optimal c‐Fos expression through DAG production. Finally, to demonstrate the importance of the M‐CSF/DGKζ/DAG axis on regulation of c‐Fos during osteoclastogenesis, we turned to PLCγ2+/‐ BMMs, which have reduced DAG levels and form fewer OCs because of impaired expression of the master regulator of osteoclastogenesis NFATc1 and c‐Fos. Strikingly, genetic deletion of DGKζ in PLCγ2+/‐ mice rescues OC formation and normalizes c‐Fos levels without altering NFATc1 expression. To our knowledge, this is the first report implicating M‐CSF/DGKζ/DAG axis as a critical regulator of bone homeostasis via its actions on OC differentiation and c‐Fos expression. © 2015 American Society for Bone and Mineral Research.
18 December 2025 in Nature Communications
IL-17A is a cytokine critical for tissue repair, but in excess, it prolongs inflammation and impairs healing. In type 2 diabetic (T2D) wounds, keratinocyte functions, including migration and inflammation, are disrupted, though mechanisms remain unclear. Here, we demonstrate that IL-17A regulates keratinocyte dysfunction via induction of the histone demethylase Jumonji domain-containing protein 3 (JMJD3) through a TRAF6/NFκB pathway. JMJD3 removes repressive histone 3 lysine 27 (H3K27me3) marks at anti-migratory (Itga3, Timp1) and inflammatory (Ccl20, Cxcl1, Cxcl3, Cxcl5) gene promoters, increasing transcription. Human and murine diabetic wounds exhibit elevated IL-17A signaling, JMJD3, and expression of associated anti-migratory and inflammatory genes compared to controls. Importantly, keratinocyte-specific deletion of IL-17A signaling or JMJD3 in diabetic mice improves wound healing and decreases expression of JMJD3 target genes. These findings reveal an IL-17A/JMJD3-mediated mechanism driving keratinocyte dysfunction in T2D wounds and highlight the therapeutic potential of targeting this axis to enhance wound repair.
1 October 2018 in Immunity